Neuromuscular blocking agents and reversal agents

被引:0
|
作者
Ahmad, Shahzaib [1 ]
Handslip, Rhodri [1 ]
机构
[1] St Georges Univ Hosp NHS Trust, Intens Care Med, London, England
关键词
Acetylcholine; aminosteroid; benzylisoquinolinium; neostigmine; neuromuscular blocking drugs; neuromuscular junction; succinylcholine; sugammadex;
D O I
10.1016/j.mpaic.2024.07.001
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The neuromuscular junction is a complex structure consisting of the muscle cell, the nerve terminal of a motor neuron and the synaptic cleft. It is the site of action for neuromuscular blocking drugs, which are a cornerstone of anaesthetic practice. These drugs can be divided into depolarizing and non-depolarizing drugs; the latter can be further subdivided into benzylisoquinolinium and aminosteroid compounds. Reversal agents are also discussed. The pharmacology of neuromuscular blocking drugs and reversal agents is discussed including mechanism of action, metabolism, factors influencing choice of drug as well as adverse effect profile.
引用
收藏
页码:595 / 599
页数:5
相关论文
共 50 条
  • [1] Neuromuscular blocking agents and reversal agents
    Pollard, Brian J.
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2005, 6 (06) : 189 - +
  • [2] The future of neuromuscular blocking agents
    Staeuble, Christiane G.
    Blobner, Manfred
    CURRENT OPINION IN ANESTHESIOLOGY, 2020, 33 (04) : 490 - 498
  • [3] Neuromuscular Blocking Agents and Reversal Agents Among Hospitalized Children: A Cerner Database Study
    Zhong Wenjun
    Liu Xinyue
    Bash, Lori D.
    Bortnichak, Ed
    Horrow, Jay
    Koro, Carol
    HOSPITAL PHARMACY, 2021, 56 (05) : 424 - 429
  • [4] Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks
    Hunter, Jennifer M.
    Blobner, Manfred
    BRITISH JOURNAL OF ANAESTHESIA, 2024, 132 (03) : 461 - 465
  • [5] Allergy to neuromuscular blocking agents
    Chiriac, Anca-Mirela
    Demoly, Pascal
    PRESSE MEDICALE, 2016, 45 (09): : 768 - 773
  • [6] Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study
    Krijtenburg, Piet
    de Boer, Arjen
    Bash, Lori D.
    Scheffer, Gert Jan
    Keijzer, Christiaan
    Warle, Michiel C.
    PERIOPERATIVE MEDICINE, 2024, 13 (01)
  • [7] History of the development of antagonists for neuromuscular blocking agents
    Suzuki, Keiko
    Takazawa, Tomonori
    Saito, Shigeru
    JOURNAL OF ANESTHESIA, 2020, 34 (05) : 723 - 728
  • [8] Appropriate Use of Neuromuscular Blocking Agents and Reversal Drugs to Enhance Recovery Following Cardiac Surgery
    Gerlach, Rebecca M.
    Chaney, Mark A.
    CURRENT ANESTHESIOLOGY REPORTS, 2020, 10 (03) : 267 - 272
  • [9] History of the development of antagonists for neuromuscular blocking agents
    Keiko Suzuki
    Tomonori Takazawa
    Shigeru Saito
    Journal of Anesthesia, 2020, 34 : 723 - 728
  • [10] Guideline on the safe use of neuromuscular blocking agents
    Nemes, Reka
    Pongracz, Adrienn
    Asztalos, Laszlo
    Nagy, Gyorgy
    Szabo-Maak, Zoltan
    Fedor, Marianna
    Fulesdi, Bela
    ORVOSI HETILAP, 2025, 166 (15) : 569 - 577